ES2176216T3 - Particulas de ceramica y su preparacion. - Google Patents

Particulas de ceramica y su preparacion.

Info

Publication number
ES2176216T3
ES2176216T3 ES94116972T ES94116972T ES2176216T3 ES 2176216 T3 ES2176216 T3 ES 2176216T3 ES 94116972 T ES94116972 T ES 94116972T ES 94116972 T ES94116972 T ES 94116972T ES 2176216 T3 ES2176216 T3 ES 2176216T3
Authority
ES
Spain
Prior art keywords
preparation
ceramic particles
particles
ferrosa
ferrita
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94116972T
Other languages
English (en)
Inventor
Aaron Gershon Filler
Andrew Michael Lindsay Lever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenix Ltd
Original Assignee
Syngenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenix Ltd filed Critical Syngenix Ltd
Application granted granted Critical
Publication of ES2176216T3 publication Critical patent/ES2176216T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Ceramic Engineering (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LAS PARTICULAS DE FERRITA QUE OBTIENEN MEDIANTE LA COPRECIPITACION DE SALES FERROSAS Y FERRICAS DE UNA SOLUCION ACUOSA, NO TIENEN OXIDOS HIDRICOS QUE SE PUEDAN QUELAR CON EDTA. POR TANTO SON PARTICULARMENTE PURAS Y ADECUADAS COMO VECTORES DE USO TERAPEUTICO O DE DIAGNOSTICO.
ES94116972T 1991-09-16 1992-09-16 Particulas de ceramica y su preparacion. Expired - Lifetime ES2176216T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119762A GB9119762D0 (en) 1991-09-16 1991-09-16 Particulate agents for nmt

Publications (1)

Publication Number Publication Date
ES2176216T3 true ES2176216T3 (es) 2002-12-01

Family

ID=10701480

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94116972T Expired - Lifetime ES2176216T3 (es) 1991-09-16 1992-09-16 Particulas de ceramica y su preparacion.

Country Status (10)

Country Link
US (2) US6153598A (es)
EP (2) EP0610232A1 (es)
JP (1) JP3560969B2 (es)
AU (1) AU669128B2 (es)
CA (1) CA2119145C (es)
DE (1) DE69232547T2 (es)
DK (1) DK0640350T3 (es)
ES (1) ES2176216T3 (es)
GB (1) GB9119762D0 (es)
WO (1) WO1993005815A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US5534423A (en) * 1993-10-08 1996-07-09 Regents Of The University Of Michigan Methods of increasing rates of infection by directing motion of vectors
US5811274A (en) * 1994-12-09 1998-09-22 The Regents Of The University Of Michigan Methods, compositions and apparatus for cell transfection
JPH11507027A (ja) * 1995-06-07 1999-06-22 シェリング アクチェンゲゼルシャフト 特定の標的構造に特異的に結合するフェライト及びオリゴヌクレオチドのコンジュゲート
AU1194697A (en) * 1995-12-21 1997-07-17 Quest International B.V. Particle compositions
FR2762615B1 (fr) * 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
US6372722B1 (en) * 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells
WO2002000870A2 (en) * 2000-06-26 2002-01-03 Christian Plank Method for transfecting cells using a magnetic field
US7589070B2 (en) * 2001-06-15 2009-09-15 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
AU2002324193A1 (en) * 2001-09-13 2003-03-24 Scientific Generics Limited Therapeutic insert and therapeutic method
US20040076966A1 (en) * 2001-10-30 2004-04-22 J. Brian Windsor Method and system for the co-isolation of cognate DNA, RNA and protein sequences and method for screening co-isolates for defined activities
US20040063158A1 (en) * 2002-09-26 2004-04-01 Ivan Alferiev Method of determining surface binding capacity
WO2005041908A1 (en) * 2003-10-29 2005-05-12 Firmenich Sa Perfume delivery systems based on inorganic nano particles
US20060263898A1 (en) * 2003-10-29 2006-11-23 Walter Paget Perfume delivery systems based on inorganic nano particles
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
DE3019764A1 (de) * 1980-05-23 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von synthetischem lepidokrokit
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4826823A (en) 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
SE8704157L (sv) * 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning
GB2221466A (en) * 1988-03-09 1990-02-07 Aluminum Co Of America Biologically reactive particles with biological, therapeutic and chromatographic applications
AU8514291A (en) * 1990-09-14 1992-04-15 St. George's Enterprises Limited Particulate agents
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
WO1992005250A1 (en) * 1990-09-25 1992-04-02 University Of Connecticut Prolonging expression of polynucleotides introduced into a cell
ES2059299T3 (es) * 1990-12-19 1997-10-01 Advanced Magnetics Inc Direccionado de agentes terapeuticos utilizando polisacaridos.
JPH06504274A (ja) * 1991-01-07 1994-05-19 シンジェニックス・リミテッド 微細粒子
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt

Also Published As

Publication number Publication date
WO1993005815A1 (en) 1993-04-01
CA2119145A1 (en) 1993-04-01
DE69232547D1 (de) 2002-05-16
AU669128B2 (en) 1996-05-30
DE69232547T2 (de) 2002-11-28
US6153598A (en) 2000-11-28
AU2567992A (en) 1993-04-27
EP0610232A1 (en) 1994-08-17
US6809082B2 (en) 2004-10-26
EP0640350B1 (en) 2002-04-10
DK0640350T3 (da) 2002-08-05
EP0640350A2 (en) 1995-03-01
CA2119145C (en) 2003-11-25
EP0640350A3 (en) 1995-12-13
US20020123478A1 (en) 2002-09-05
JP3560969B2 (ja) 2004-09-02
JPH07501793A (ja) 1995-02-23
GB9119762D0 (en) 1991-10-30

Similar Documents

Publication Publication Date Title
ES2176216T3 (es) Particulas de ceramica y su preparacion.
ES2012739A4 (es) Vacunas y diagnosticos nanbv.
BE855549A (fr) Champs chirurgicaux
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
ATA28376A (de) Kranken- bzw. nachtstuhl
IT8183375A0 (it) Schienale per sedia e sedia o poltroncina dotata del detto schienale.
DE3789583D1 (de) Hochfeste Zirkonoxid-Keramik.
DE68904147D1 (de) Kronenetherverbindung und trennmittel.
IT8920413A0 (it) Procedimento per la preparazione di l alfa glicerilfosforilcolina e l alfa glicerilfosforiletanolammina.
BR7703370A (pt) Cadeira de paciente
TR20736A (tr) Flor-suebstitueye fenoksibenziloksikarbonil tuerevleri bunlarin,hazirlanisi icin usuller ve bunlarin ensektisidler ve akarisidler olarak kullanilmalari
DE3680838D1 (de) Stabilisierte menschliche prourokinase.
NL7806573A (nl) Preparaten met geneeskundige werkzaamheid.
NL7800169A (nl) Farmaceutische preparaten met anti-ulcuswerking in het maag-darmkanaal.
DE59104783D1 (de) Patientenuntersuchungstisch.
NL7700293A (nl) Tandartsstoel.
IT8747551A0 (it) 8 alfa acilamminoergoline ,loro preparazione e loro impiego come medicamenti
BR7703447A (pt) Cadeira de paciente
IL52278A (en) -dialkoxymethyl- -formyl(or carbaloxy)- phenyl-propionitriles, their preparation and their use as intermediates in the preparation of trimethoprim and some
NO900564L (no) Overflateaktivt middel.
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
IT8025482A0 (it) Membrana modificata morfologicamente ed uso della stessa in procedimenti di elettrolisi.
JPS522433A (en) Single bath color element silver branching liquid
IT8019370A0 (it) Struttura di sedia o poltrona.
MX9203757A (es) Derivado de eritromicina y la preparacion y uso del mismo.